UK scientists call for £100 million UK stem cell fund:
This article was originally published in Clinica
Executive Summary
UK scientists and entrepreneurs are calling for the creation of a charitable Stem Cell Foundation to ensure that commercial enterprise matches the investment and know-how that is putting the UK at the forefront of the technology. A £100m ($186m) fund would help cement that leadership, said bioscientist and venture-capitalist Professor Sir Chris Evans, chairman of Merlin Bioscience, who presented the idea at a meeting of stem cell experts at the Centre for Life, in Newcastle, this week. The technology is seen as being at the heart of the future revolution that regenerative medicine will bring - as such, it is being compared to penicillin and scanners, as examples of medical developments that the UK has failed to exploit commercially.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.